In a patient with asthma who has a chest infection, what is the most appropriate first‑line antibiotic to prescribe?

Best Antibiotic for Chest Infection in Asthma Patient

Antibiotics should only be prescribed if there is documented bacterial infection—they are not routinely indicated for asthma exacerbations or chest infections without clear evidence of bacterial involvement. 1, 2, 3

When Antibiotics Are NOT Indicated

• Viral respiratory infections (the most common cause of asthma exacerbations, particularly rhinovirus) do not benefit from antibiotics 2
• Purulent sputum alone is not a reliable indicator of bacterial infection, as eosinophilic inflammation in asthma can also discolor sputum 2
• Routine antibiotic use in asthma exacerbations without documented bacterial infection provides no benefit and only two small trials (121 patients total) have addressed this question, showing no advantage 2

When Antibiotics ARE Indicated

Prescribe antibiotics only when there is:

• Radiographic evidence of pneumonia (lobar consolidation on chest X-ray) 1
• Fever with documented bacterial infection 1
• Clinical signs of bacterial pneumonia (not just bronchitis) 4, 5

First-Line Antibiotic Choice for Community-Acquired Pneumonia

For outpatient management without cardiopulmonary disease or risk factors for drug-resistant Streptococcus pneumoniae (DRSP):

• Amoxicillin 500–1000 mg every 8 hours is the preferred first-line agent 4, 6
• Alternative: Amoxicillin-clavulanate 1 g every 8 hours if β-lactamase-producing Haemophilus influenzae is prevalent in your region 4, 6

For patients with risk factors for DRSP (recent antibiotic use within 4–6 weeks, age >65, immunocompromised, diabetes, chronic cardiac/hepatic/renal disease):

• High-dose amoxicillin-clavulanate (2 g twice daily or 4 g/250 mg daily) 7, 6, 5
• This provides coverage for penicillin-nonsusceptible pneumococcus 7, 6

For Penicillin-Allergic Patients

• Doxycycline 100 mg every 12 hours 4, 6
• Respiratory fluoroquinolone (levofloxacin or moxifloxacin) for severe infection 4, 6, 5
• Avoid macrolides (azithromycin, clarithromycin) as first-line due to high resistance rates in S. pneumoniae (>40% in many regions) 7, 6

For Hospitalized Patients

Medical ward (non-ICU):

• Second- or third-generation cephalosporin (cefuroxime 750–1500 mg IV every 8 hours, or ceftriaxone 1 g IV daily) PLUS a macrolide (erythromycin 1 g IV every 8 hours or azithromycin) 4, 5
• Alternative: Antipneumococcal fluoroquinolone monotherapy (levofloxacin or moxifloxacin) 5

ICU admission:

• β-lactam active against DRSP (cefotaxime, ceftriaxone) PLUS either azithromycin or a fluoroquinolone 5
• If aspiration or lung abscess suspected: Amoxicillin-clavulanate 2 g IV every 6 hours or add clindamycin 600 mg IV every 8 hours 4, 5

Duration of Treatment

• Minimum 7–10 days for community-acquired pneumonia 4, 6
• 10–14 days for bacterial exacerbations in chronic lung disease 8
• Shorter courses (5 days) may be adequate for uncomplicated cases with good clinical response 7

Critical Pitfalls to Avoid

• Do not prescribe antibiotics for asthma exacerbations without documented bacterial infection—this is explicitly contraindicated 1, 2, 3
• Do not use trimethoprim-sulfamethoxazole due to high resistance rates (50% in S. pneumoniae, 27% in H. influenzae) 7, 9
• Avoid fluoroquinolones as first-line unless penicillin allergy or treatment failure, due to adverse effects and resistance concerns 7, 10
• Macrolides should not be used alone for empiric pneumonia treatment due to resistance 7, 6